V Researchers

Success Stories

Luis Carvajal-Carmona, Ph.D.

January 21, 2015 Hispanic women have a lower risk of developing breast cancer than their Caucasian, African-American or Asian counterparts. Dr. Luis Carvajal-Carmona, a 2013 V Scholar Grant recipient from The University of California, Davis, and his colleagues have discovered a BRCA1 mutation or variant in the genetic sequence upstream of the estrogen receptor gene on Chromosome 6 that may partly explain this phenomenon. This variant is relatively common in Latin American populations but is almost absent from people of European, African American and Chinese heritage. Read more here …

Read More...

Mo Motamedi, Ph.D.

January 21, 2015 Dr. Mo Motamedi at Massachusetts General Hospital in Boston has been using his 2012 V Scholar Grant to research cancer through a study of yeast cells. The genes that humans share with yeast are the most elemental and vital genes an organism needs for life. Against this simple genetic background, Dr. Motamedi looks for the effects of a molecular memory system—called epigenetics—which keeps the inheritance of genes ‘true’ during rounds of cell division in both yeast and humans. Dr. Motamedi’s research may lead to the development of new drugs and new strategies for reprogramming cancer cells to […]

Read More...

Benjamin Ebert, M.D., Ph.D.

December 4, 2014 Dr. Benjamin Ebert, a 2013 V Foundation Translational Grant recipient, and his team at Brigham and Women’s Hospital in Boston have recently published an intriguing study that looked at pre-cancer signs in blood cancers. Dr. Ebert led one of two research teams that worked independently on decoding DNA in about 30,000 people. Blood cancers account for about 10% of new cancer cases diagnosed in the United States. The cells that cause cancer must mutate several times before the cancer actually develops. Dr. Ebert and his team aimed to find that initial mutation in the cell so that […]

Read More...

Nora Heisterkamp, Ph.D.

July 8, 2014 V Foundation Translational Grant recipient Dr. Nora Heisterkamp and her colleagues at The Saban Research Institute of Children’s Hospital Los Angeles recently published significant research findings regarding acute lymphoblastic leukemia (ALL) in Molecular Cancer Therapeutics. ALL, which is more common in children, is characterized by an overproduction of immature white blood cells (lymphoblasts). The lymphoblasts continuously multiply in the bone marrow, causing the damage or destruction of normal blood cells. Dr. Heisterkamp and her team have discovered that by using an antibody to target a particular receptor found on chemotherapy-resistant cells, they can selectively kill cancer cells […]

Read More...

Zachary T. Schafer, Ph.D.

May 27, 2014 A team of researchers led by 2011 V Scholar Grant recipient Dr. Zachary T. Schafer, Coleman Assistant Professor of Cancer at The University of Notre Dame, has uncovered important new data about carcinoma-associated fibroblasts (CAFs) and their role in tumor biology. CAFs play a major role in tumor progression, but exactly how is not understood. In their paper, Dr. Schafer and his team describe a critical role of CAFs in blocking anoikis, a cell death process that inhibits the spread of tumor cells to distant sites, through the secretion of insulin-like growth factor-binding proteins (IGFBPs). They revealed the […]

Read More...

Timothy Burns, M.D., Ph.D.

November 21, 2013 Lung cancer is the leading cause of cancer death. More people die of lung cancer than of colon, breast and prostate cancers combined. Finding the right therapy for lung cancer has proven difficult. Recent research has focused on sequencing different lung cancer mutations and allowing researchers to identify effective drug variations for some of those mutations. Dr. Timothy Burns is a 2013 V Scholar Grant recipient with a personal connection to lung cancer. Having lost both parents to the disease, he is focused on researching targeted therapies for the KRAS mutation of non-small cell lung cancer. The […]

Read More...

Glenn Bubley, M.D.

November 14, 2013 Dr. Glenn Bubley is the Associate Professor of Medicine at Harvard Medical School, Director of Genitourinary Oncology at Beth Israel Deaconess Medical Center and a 2012 Translational Grant recipient. He collaborated on the recent peer-reviewed article ‘Subjective Endpoints in Clinical Trials: The Case for Blinded Independent Review,’ published in Open Access Journal of Clinical Trials. Dr. Bubley’s article distills ten years of experience with Endpoint Assessment Committee (EAC) work to provide a process map for maximizing the precision and accuracy of independent reviews of clinical trials. According to WorldCare Clinical, primary efficacy and safety endpoints are often […]

Read More...

Rameen Beroukhim, M.D., Ph.D.

November 6, 2013 The Cancer Genome Atlas, a project launched by America’s National Institutes of Health, has assembled genetic data on thousands of tumors and made it available to anyone who wants to analyze it. Thanks to these DNA sequencing studies, researchers have unprecedented information on the molecular changes which propel cancer. Dr. Rameen Beroukhim, a 2009 V Scholar, is one of the researchers making sense of the data and putting it to use. He has examined almost 5,000 specimens from 11 traditionally defined types of cancer and found 140 regions of DNA that were sometimes either multiplied repeatedly or […]

Read More...

Judy Garber, M.D., M.P.H.

October 31, 2013 Dr. Judy Garber received a Translational Grant from The V Foundation in 2008 to support her breast cancer research. She is the director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute and has recently been elected to the Institute of Medicine (IOM), a nongovernmental organization that advises the nation on issues related to biomedical science, medicine and health. With breast cancer as their primary focus, Dr. Garber and her colleagues are leading studies of the long-term psychosocial and medical effects of genetic testing. Her work centers on identifying people with genetic factors […]

Read More...

Lisa Diller, M.D.

September 18, 2013 Dr. Lisa Diller received a Translational Grant in 2012 from The V Foundation to further her research for pediatric cancer. She works at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as Chief Medical Officer. To recognize September as Childhood Cancer Awareness Month, Dr. Diller is reminding parents to stay strong for the 12,000 children battling cancer in the United States. Since the 1970s, the five-year survival rate for pediatric cancer has increased from 58 percent to 83 percent. Here is a complete list of tips for parents with children battling cancer.

Read More...